Learn languages naturally with fresh, real content!

tap to translate recording

Explore By Region

flag Sun Pharma and Moebius Medical receive Fast Track designation for non-opioid osteoarthritis knee pain treatment MM-II.

flag Sun Pharma and Moebius Medical have received Fast Track designation from the FDA for MM-II, a non-opioid treatment for osteoarthritis knee pain. flag This product employs a unique suspension of large liposomes aimed at reducing joint friction and pain. flag The Fast Track program facilitates quicker review and approval processes for serious conditions. flag The companies plan to begin Phase 3 trials and pursue a CE Mark in the EU.

8 months ago
5 Articles